This medicine must not be administered in the following situations: hypersensitivity to alfuzosin and/or any of the other components, postural hypotension, hepatic insufficiency, combination with other alpha 1-blockers, severe kidney failure (creatinine clearance < 30 ml/min), concomitant administration with potent CYP3A4 inhibitors (see INTERACTIONS).